Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 202

Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 2024-2030

The Medical Affairs Outsourcing Market size was estimated at USD 9.78 billion in 2023 and expected to reach USD 11.16 billion in 2024, at a CAGR 14.59% to reach USD 25.39 billion by 2030.

Medical affairs is an essential function within the life sciences industry, encompassing a wide range of activities that bridge the gaps between clinical development, commercialization, and engagement with healthcare stakeholders. Medical affairs outsourcing refers to the practice of entrusting these activities, including medical writing, medical communications, publication planning, field medical engagement, medical information services, and health economics and outcomes research (HEOR) to external organizations with specialized expertise. As therapies become more complex, the demand for specialized medical affairs services grows. Companies entering new markets also seek local medical affairs support to navigate different regulatory landscapes. The robust pipeline of pharmaceutical and biotech companies broadens the potential for outsourcing services. However, challenges such as ensuring data security and maintaining quality control remain significant hurdles. While market players are focusing on improving service compliance and offerings, they are also developing tailored medical affairs strategies to support personalized therapies and are leveraging real-world evidence to demonstrate product value and inform clinical strategies. Digitalization and AI in medical affairs could also offer innovative outsourcing services.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a significant emphasis on compliance and transparency in pharmaceutical operations. Firms in these regions often outsource medical affairs activities to maintain high levels of regulatory compliance and to gain strategic insights from external experts. With a highly developed pharmaceutical industry, the Americas generally show a mature outsourcing market characterized by the engagement of sophisticated CROs and medical affairs service providers. The APAC region is marked by its diverse healthcare markets, with countries at different stages of pharmaceutical industry development. Outsourcing in APAC is rapidly growing, driven by the emergence of local players and increasing investments by global companies. The rise in the number of clinical trials, growing demand for specialized medical services, and cost advantages are significant factors contributing to the expansion of Medical Affairs outsourcing in APAC. Companies in APAC turn to outsourcing to gain access to regional expertise, expand their market reach, and capitalize on the growing healthcare needs of populous countries, including China and India. EMEA encompasses a vast region with a wide variety of healthcare systems and regulatory environments. In Europe, medical affairs outsourcing is well-established, with many companies leveraging the services of CROs and other specialized firms, particularly for market access and health economics outcomes research (HEOR). The Middle East and Africa are emerging markets for outsourcing, with multinational companies exploring these regions for expansion.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Medical Affairs Outsourcing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Expansion of pharmaceutical pipeline and growing complexity of clinical data
Increase in the volume of medical publications and educational content
Rising demand for evidence-based medicine and value-based healthcare

Market Restraints

Limitations associated with communication and quality of outsourced functions

Market Opportunities

Inclusion of AI & ML technologies in medical affairs outsourcing
Strategic collaborations between pharmaceutical companies and outsourcing firms

Market Challenges

Concerns associated with confidentiality and data security risks

Market Segmentation Analysis

Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways
Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis
End User: Diverse applications across end-users for operational cost efficiency

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Affairs Outsourcing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Affairs Outsourcing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic

NAMSA, the renowned MedTech CRO, announced a strategic outsourcing partnership with Terumo Aortic, innovators in aortic disease treatment solutions. With NAMSA's commitment to offer immediate access to clinical experts and high-caliber cardiovascular teams, the partnership embodies a robust fusion of expertise designed to navigate regulatory landscapes, streamline clinical trials, and push through market barriers.

Millstone Medical Outsourcing Completes Clean Room Facility Expansion

Millstone Medical Outsourcing has completed its third infrastructure enhancement by adding an additional 5,000 square feet of Class 10,000/ISO7 cleanroom space. This expansion is a testament to Millstone Medical Outsourcing commitment to fulfilling the surge in requirements for its Tier 1 services, offering Original Equipment Manufacturers (OEMs) comprehensive solutions spanning from quality inspection to cleanroom packaging and assembly.

ONO and Bristol Myers Squibb Sign Outsourcing Agreement with PRiME-R on Clinical Research of Opdivo in Patients with Gastric Cancer, utilizing CyberOncology in Japan

Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb K.K., have embarked on a novel collaboration with Prime Research Institute for Medical RWD, Inc. by signing a groundbreaking outsourcing agreement. This agreement is set to pioneer a substantial industry-led, multi-center clinical study examining the treatment of gastric cancer using Opdivo (nivolumab) in conjunction with chemotherapy. Utilizing the innovative CyberOncology data support system from PRiME-R, the research will harness structured real-world data from routine clinical practice to evaluate treatment outcomes.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Affairs Outsourcing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
Medical Communications
Medical Information Services
Medical Monitoring
Medical Science Liaisons
Medical Writing & Publishing
Operational Model
Full-Service Outsourcing
Functional Outsourcing
Partial/Task-based Outsourcing
End-User
Biotechnology & Pharmaceutical Companies
Contract Research Organization
Hospitals
Medical Device Companies
Nursing Homes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year